Wednesday, December 24, 2014

Gynostemma antitumorigenic activities of Honokiol

Honokiol has apparent pro-apoptotic furnishings in melanoma, sarcoma, myeloma, leukemia, bladder, lung, prostate, articulate squamous corpuscle carcinoma, in glioblastome multiforme beef and colon blight corpuscle lines. Honokiol inhibits phosphorylation of Akt, p44/42 mitogen-activated protein kinase (MAPK), and src. Additionally, honokiol regulates the nuclear agency kappa B (NF-κB) activation pathway, an upstream effector of vascular endothelial advance agency (VEGF), MCL1, and cyclooxygenase 2 (COX-2), all cogent pro-angiogenic and adaptation factors. Honokiol induces caspase-dependent apoptosis in a TRAIL-mediated manner, and potentiates the pro-apoptotic furnishings of doxorubicin and added etoposides. So almighty is honokiol's pro-apoptotic furnishings that it overcomes even awfully biologic aggressive neoplasms such as assorted myeloma and abiding B-cell leukemia. Honokiol aswell acts on the PI3K/mTOR alleyway in bump beef while advancement alleyway action in T cells.
more about:
godowell.net/HerbalExtract/Honokiol/

No comments:

Post a Comment